This November, We are grateful for the dogs who are our partners in advancing osteosarcoma research. In honor of Pet Cancer Awareness Month this November, explore our Canine Clinical Trial Resource and consider submitting to the Discover Oncology Comparative Oncology Special Issue: Making It Better for Osteosarcoma. This month, we’re spotlighting the Carter family and their inspiring efforts to honor Scott Carter’s legacy through research, advocacy, and community. Be sure to save the date for Giving Tuesday on December 2, a day dedicated to giving back and supporting our mission. Help our OsteoWarriors feel the holiday magic—choose a gift from their Amazon List to Santa and send it by December 8. Together, we are Making It Better.
With hope,
The MIB Agents Team
.png)
The Carter family’s dedication to the osteosarcoma community began with Scott Carter’s dream to help fund cancer research. In his memory, the family established the Scott Carter Foundation, which has since raised millions to support pediatric cancer research. Their involvement has continued to grow—Luke now serves on MIB Agents’ Junior Advisory Board, participates in Climb the Hill, and leads the family’s new initiative, MilesCount, extending their impact even further. Together, they are helping drive progress and hope for families affected by osteosarcoma.
.png)
This Giving Tuesday, join us in supporting OsteoWarrior families and the programs that bring hope, comfort, and resources to children facing osteosarcoma and their loved ones. Every gift, big or small, makes a difference. Let’s come together to Make It Better this giving season!
Support MIB Agents for Giving Tuesday
If you have a job posting and you would like it included here, please email christina@mibagents.org.
Bone cancer in dogs occurs far more frequently than in people, providing a critical opportunity to study the disease and identify new treatment strategies that benefit both species. The MIB Agents Canine Clinical Trials resource page features a list of veterinary oncology programs in the US and Canada, and ongoing osteosarcoma canine trials, with links to participating institutions and study details. Explore the page to learn how this research is driving progress for both dogs and humans with osteosarcoma.
Learn About Canine Clinical Trials
Warrior Mail Holiday Issue needs assistance from our loving elves! Please have a look through our OsteoWarrior's list to Santa on Amazon to select a gift or two! All purchases must ARRIVE to us no later than December 8th.
Discover Oncology is launching a special issue: Making It Better for Osteosarcoma: Translational Research, Comparative Oncology, and Beyond, edited by Alicia Viloria-Petit, MSc, PhD (Ontario Veterinary College, University of Guelph). Inspired by MIB Agents, this collection seeks studies that identify the key tools we still need to truly make it better for osteosarcoma patients.
Topics of interest include: translational and comparative oncology in canine and human osteosarcoma, integrative studies at the intersection of sociology, psychology, and oncology, and research that amplifies the voices of patients, families, and advocates. Together, these perspectives aim to advance outcomes and improve quality of life for all those affected by osteosarcoma.
Submission deadline: May 4, 2026
.png)
Have a compelling topic to share with the osteosarcoma community? We want to hear about it! MIB Agents is now accepting abstract submissions for our FACTOR 2026 conference, June 25-27, 2026 in Columbus, OH. Abstracts will be considered for oral presentation or poster presentation. Submissions are due online at Proposal Central on January 9, 2026.
